| Scientific Name |
Natalizumab
|
|---|---|
| Brand Name |
Tysabri
|
| Risk |
Risk of progressive multifocal leukoencephalopathy PML.
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|